Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

India’s Zydus Cadila Buys Majority Stake In South Africa’s Simayla Pharmaceuticals

This article was originally published in PharmAsia News

Executive Summary

NEW DELHI - Indian generic drug firm Zydus Cadila said a wholly-owned unit bought a 70 percent stake in South Africa's Simayla Pharmaceuticals of South Africa at an undisclosed price to expand market share in the cardiovascular, anti-infective, respiratory, gastrointestinal and women's healthcare segments

You may also be interested in...



India’s Zydus Buys Laboratories Combix Of Spain For Generics Market

Zydus Cadila of India said it has acquired the assets of Laboratories Combix of Spain, but did not disclose the purchase amount. A Zydus official said the takeover would help the firm establish itself as a global health care provider in addition to making generic drugs. The official said Zydus was counting on a rapidly growing market for generics in Spain, already considered the world's fifth-largest market for pharmaceuticals. Combix already has a portfolio of 17 molecules. (Click here for more

PharmAsia News Business Bulletin

A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).

PharmAsia News Business Bulletin

A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).

UsernamePublicRestriction

Register

MT125590

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel